| Mesothelial Neoplasm studied in …STUDIED_INderived200 of 521show all (up to 200) |
|---|
| → studied in | NCT05304208Phase 1 · recruiting dENdritic Cell Therapy Combined With SURgEry in Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04431024recruiting Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07277413Phase 1 · recruiting A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04981119recruiting Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06581549completed Immune Microenvironment and Gene Expression Profiling in Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06037941NA · recruiting Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06057935Phase 2 · recruiting A Study of Additional Chemotherapy After Surgery for People With Malignant Peritoneal Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05960773Phase 2 · recruiting Decitabine/Cedazuridine (INQOVI), an Oral DNA Demethylating Agent, in Subjects With BAP1 Cancer Predisposition Syndrome and Subclinical, Early-Stage Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05001880Phase 2 · recruiting Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04031469suspended A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Disease · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705334Phase 1 · recruiting A Study of SHY-ONC6, a Novel Proteasome Inhibitor, in Adults With Advanced or Metastatic Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00541073Phase 2 · completed Pemetrexed, Cisplatin, and Vitamin B12 in Treating Patients With Mesothelioma of the Chest That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07824986Phase 3 · not yet recruiting A Phase 3 Trial in Advanced Epithelioid Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06318286Phase 2 · active not recruiting Study of Pembrolizumab Plus Chemotherapy With Lenvatinib for Malignant Pleural Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06566079Phase 1/Phase 2 · recruiting Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped CURATED_BROADER · 521 trials mapped (127 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04162015Phase 1 · active not recruiting A Study of Nivolumab and Chemotherapy Followed by Surgery for Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01064648Phase 1/Phase 2 · active not recruiting Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01617382recruiting Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05245500Phase 1 · recruiting Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06251310Phase 1 · recruiting SW-682 in Advanced Solid Tumors · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01950572recruiting Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03830229recruiting Long Term Follow-Up of Patients With Mesothelioma and Individuals With Germline Mutations in BAP1 · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06885697Phase 1 · recruiting Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03007030Phase 2 · active not recruiting Brentuximab Vedotin in Treating Patients With CD30+ Malignant Mesothelioma That Cannot Be Removed by Surgery · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04670445NA · completed Improving Patient and Caregiver Understanding of Risks and Benefits of Immunotherapy for Advanced Cancer · condition mapped CURATED_BROADER · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04847063Phase 1 · recruiting Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04104776Phase 1/Phase 2 · recruiting A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03654833Phase 2 · completed Mesothelioma Stratified Therapy (MiST) : A Multi-drug Phase II Trial in Malignant Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00715611Phase 2 · active not recruiting Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07234058Phase 2 · recruiting Trial Assessing Fianlimab Plus Cemiplimab Plus Chemotherapy or Cemiplimab Plus Chemotherapy in Patients With Pleural Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04106973terminated Mesothelioma Early Detection by VOCs · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06840834Phase 2 · recruiting Evaluating Ivonescimab as a Potential Treatment for Pleural Mesothelioma Patients Whose Cancer Has Returned After Previous Immunotherapy and Chemotherapy · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05647265Phase 2 · recruiting Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Pleural Biphasic Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03228537Phase 1 · active not recruiting Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Biphasic Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05579366Phase 1/Phase 2 · recruiting Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07192900Phase 1 · recruiting Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02535312Phase 1/Phase 2 · active not recruiting Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin · condition mapped CURATED_BROADER · 521 trials mapped (127 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04491942Phase 1 · active not recruiting Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer · condition mapped CURATED_BROADER · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05703854Phase 1/Phase 2 · suspended Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and Osteosarcoma · condition mapped CURATED_BROADER · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06097728Phase 3 · active not recruiting MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma · condition mapped CURATED_BROADER · 521 trials mapped (127 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07713732Phase 1 · not yet recruiting TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors · condition mapped PROBABILISTIC · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04577326Phase 1 · active not recruiting Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05278975Phase 1/Phase 2 · completed Study of RSO-021 in Patients With Malignant Pleural Effusion Due to Advanced/Metastatic Solid Tumors Including Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03917043Phase 1 · recruiting APG-2449 in Patients With Advanced Solid Tumors · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05714553Phase 1/Phase 2 · terminated NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02414269Phase 1/Phase 2 · active not recruiting Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03075527Phase 2 · terminated A Phase 2 Study of Durvalumab in Combination With Tremelimumab in Malignant Pleural Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07705074Phase 1/Phase 2 · not yet recruiting FAPI PET Imaging - An Exploratory Study · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04158141Phase 3 · terminated Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Pleural Biphasic Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05451849Phase 1/Phase 2 · terminated A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05628376recruiting TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05873686Phase 1 · recruiting A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04926948Phase 1 · completed Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06466187Phase 1 · terminated A Study of SGN-MesoC2 in Advanced Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06996249recruiting Prospective Data Collection Initiative on Thoracic Malignancies · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06710756Phase 1/Phase 2 · recruiting Lead-212 PSV359 Therapy for Patients With Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03874455no longer available Tazemetostat Expanded Access Program for Adults With Solid Tumors · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05571839Phase 1 · terminated A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02012699recruiting Integrated Cancer Repository for Cancer Research · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790706Phase 2 · active not recruiting IMMUNORARE5: A National Platform of 5 Academic Phase II Trials Coordinated by Lyon University Hospital to Assess the Safety and the Efficacy of the IMMUNOtherapy With Domvanalimab + Zimberelimab Combination in Patients With Advanced RARE Cancers · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05568680Phase 1 · recruiting SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04857372Phase 1 · active not recruiting A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06971848NA · recruiting Evaluation of Skin Tests in Biotherapy Allergies · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07330271NA · recruiting PTC-Guided Therapy for Peritoneal Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06051695Phase 1/Phase 2 · recruiting A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06756035Phase 1 · recruiting CT-95 in Advanced Cancers Associated With Mesothelin Expression · condition mapped CURATED_BROADER · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03918252Phase 2 · active not recruiting Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05765084Phase 1/Phase 2 · recruiting Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03935893Phase 2 · active not recruiting Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid Cancers · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06477419Phase 2 · recruiting A Study of Sacituzumab Govitecan in People With Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02959463Phase 1 · completed Pembrolizumab After Radiation Therapy in Treating Patients With Pleural Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07602946Phase 2 · not yet recruiting SELECTmeso A Trial for Patients With Relapsed Malignant Mesothelioma SELECTmeso1 A Trial of BMS-986504 in Patients With MTAP-deficient Relapsed Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06885424enrolling by invitation A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06503146Phase 2 · recruiting 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01552434Phase 1 · terminated Bevacizumab and Temsirolimus Alone or in Combination With Valproic Acid or Cetuximab in Treating Patients With Advanced or Metastatic Malignancy or Other Benign Disease · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02399371Phase 2 · completed Pembrolizumab in Treating Patients With Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Biphasic Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03684486NA · terminated Rehabilitation by Effort for Patients With Advanced Bronchial Cancer · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01851395terminated Rapid Autopsy and Procurement of Cancer Tissue · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03683680NA · recruiting Prospectively Collected Pleural Biopsies for Validation of Malignant Pleural Mesothelioma Prognostic Biomarkers · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05337735Phase 2 · suspended A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07563738Phase 1/Phase 2 · recruiting A 2-part Phase 1/2 Open-label Trial on ODM-212 · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07561190recruiting Multidimensional Omics Analysis in Malignant Pleural Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07550049not yet recruiting Comprehensive Oncogenomic Mapping and Exploration in Thoracic and Head & Neck Oncology · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03710876Phase 3 · completed Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03881488Phase 1 · completed Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06638931Phase 2 · recruiting Agnostic Therapy in Rare Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04375267Phase 1 · completed 177Lu-DOTA-TATE and Olaparib in Somatostatin Receptor Positive Tumours · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05461430completed Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06362369Phase 1/Phase 2 · recruiting A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06444815Phase 1 · recruiting A Study of VET3-TGI in Patients With Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07443020Phase 1 · recruiting Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07514793Phase 2 · not yet recruiting Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07510815Phase 1/Phase 2 · recruiting Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma · condition mapped PROBABILISTIC · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04665206Phase 1/Phase 2 · recruiting Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03126630Phase 1/Phase 2 · active not recruiting Pembrolizumab With or Without Anetumab Ravtansine in Treating Patients With Mesothelin-Positive Pleural Mesothelioma · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05655078NA · recruiting Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03678350Phase 1 · completed Light Dosimetry for Photodynamic Therapy With Porfimer Sodium in Treating Participants With Malignant Mesothelioma or Non-Small Cell Lung Cancer With Pleural Disease Undergoing Surgery · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04234113Phase 1 · terminated Study of Nanrilkefusp Alfa Alone and With Pembrolizumab in Adult Patients With Advanced/Metastatic Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04450043NA · active not recruiting The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03420963Phase 1 · terminated Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors · condition mapped CURATED_BROADER · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06654050Phase 2 · withdrawn Alrizomadlin (APG-115) in Subjects With BAP1 Cancer Syndrome and Early-Stage Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04897022Phase 1 · active not recruiting A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04792463recruiting Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00797719Phase 1/Phase 2 · completed Short Neoadjuvant Hemithoracic IMRT for MPM · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04028570NA · active not recruiting A Feasibility Study Evaluating Surgery for Mesothelioma After Radiation Therapy Using Extensive Pleural Resection · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07449624completed From Presentation to Diagnosis: Patterns of Pleural Effusion · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07420010early Phase 1 · not yet recruiting An Open-label, Single-arm Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile, and Preliminary Efficacy of KT032 Cell Injection in Patients With Mesothelin-positive Advanced Solid Tumors. · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07126509NA · recruiting Partial Pleurectomy (Surgery) for Unresectable Pleural Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07403630NA · recruiting INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03875144Phase 2 · suspended Treatment of Malignant Peritoneal Mesothelioma (MESOTIP) · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02662504Phase 2 · completed Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04166734Phase 1 · terminated Pembrolizumab and Hypofractionated Stereotactic Radiotherapy in Patients With Malignant Pleural Mesothelioma · condition mapped CURATED_BROADER · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05136677Phase 2 · completed A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04334759Phase 3 · completed DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05070247Phase 1/Phase 2 · terminated A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03269227NA · active not recruiting Accelerated Hypofractionated Radiotherapy in the Treatment of Malignant Pleural Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06155279Phase 2 · active not recruiting Induction Chemo+Immunotherapy in Resectable Epithelioid and Biphasic Pleural Mesothelioma (CHIMERA Study) · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05544929Phase 1 · active not recruiting A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05380713Phase 2 · completed ......SMARTEST Trial...... · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01385722enrolling by invitation Molecular Analysis of Thoracic Malignancies · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05005429Phase 2 · completed Study of the Efficacy and Safety of the Bintrafusp Alfa in Previously Treated Advanced Malignant Pleural Mesothelioma · condition mapped PROBABILISTIC · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07282873Phase 1/Phase 2 · not yet recruiting Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02611037Phase 2 · completed Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03556228Phase 1/Phase 2 · recruiting VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03760575Phase 1 · recruiting Pembrolizumab in Combination With Chemotherapy and Image-Guided Surgery for Malignant Pleural Mesothelioma (MPM) · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03983954Phase 1 · active not recruiting Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer. · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05795595Phase 1/Phase 2 · completed A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05238883Phase 1 · active not recruiting A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05730816Phase 2 · recruiting MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04115254NA · recruiting Stereotactic Magnetic Resonance Guided Radiation Therapy · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02875548Phase 1/Phase 2 · completed A Study to Assess Long-term Safety of Tazemetostat in Adult Participants of All Ages With Any Disease Treated With Tazemetostat in a Previous Clinical Study · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06538376NA · recruiting Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04272034Phase 1 · terminated Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05308966completed Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE) · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04914897Phase 2 · terminated A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With Lung Cancer or Mesothelioma (Pegathor Lung 202) · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04400539Phase 2 · recruiting The IMmunotherapy Pleural 5-ALA PDT · condition mapped PROBABILISTIC · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05932199Phase 1/Phase 2 · recruiting Neoadjuvant Durvalumab and Tremelimumab With and Without Chemotherapy for Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02628067Phase 2 · active not recruiting Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158) · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02863055Phase 2 · terminated Nintedanib as Switch Maintenance Treatment of Pleural Malignant Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05107674Phase 1 · recruiting A Study of NX-1607 in Adults With Advanced Malignancies · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05449366Phase 1/Phase 2 · completed Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Peritoneal Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03907852Phase 1/Phase 2 · active not recruiting Phase 1/2 Trial of Gavo-cel (TC-210) in Patients With Advanced Mesothelin-Expressing Cancer · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05538806recruiting TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07131345Phase 1/Phase 2 · not yet recruiting Study of Iparomlimab and Tuvonralimab Plus Chemotherapy in Malignant Mesothelioma · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07121374Phase 1/Phase 2 · recruiting NEoadjuvant Chemotherapy and Immunotherapy for a Selected Group of Inoperable Pleural Mesothelioma Patients (NECIM): a Feasibility Study · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Pleural Epithelioid Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02903914Phase 1 · completed Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06299163Phase 1 · terminated NM32-2668 in Adult Patients With Selected Advanced Solid Tumors · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07072143recruiting An International Study on Pediatric Patients With Rare Tumors. · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04153565Phase 1 · completed A Study of Pembrolizumab in Combination With Cisplatin and Pemetrexed in Advanced Malignant Pleural Mesothelioma (MPM) (MK-3475-A17) · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00354393Phase 2 · completed Combination Chemotherapy With or Without Surgery & Chemoradiotherapy in Patients With Malignant Pleural Mesothelioma · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02613299terminated Surgery for Mesothelioma After Radiation Therapy "SMART" for Resectable Malignant Pleural Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04242199Phase 1 · completed Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05563272Phase 2 · terminated 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02611024Phase 1/Phase 2 · completed Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05086692Phase 1/Phase 2 · recruiting A Beta-only IL-2 ImmunoTherapY Study · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06790082Phase 2 · recruiting The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02078700Phase 2 · completed Feasibility of an Early Palliative Care Intervention for Metastatic Cancer Patients. A Phase 2 Study. · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04525859Phase 1 · completed Poly-ICLC (Hiltonol®) Vaccine In Malignant Pleural Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05944237Phase 1/Phase 2 · recruiting HTL0039732 in Participants With Advanced Solid Tumours · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00629343Phase 1 · completed Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04214015withdrawn A Pilot Study to Explore the Role of Gut Flora in Metastatic Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05188859Phase 2 · recruiting First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05455424Phase 2 · completed Niraparib Efficacy in Patient With Unresectable Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04040231Phase 1 · completed Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04515836Phase 2 · recruiting Olaparib in Patients With HRD Malignant Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02649829Phase 1/Phase 2 · completed Autologous Dendritic Cell Vaccination in Mesothelioma · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06946498NA · recruiting First Local Anaesthesia Thoracoscopy for Pleural Effusion Diagnosis. · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04301011Phase 1 · terminated Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03063450Phase 3 · completed CheckpOiNt Blockade For Inhibition of Relapsed Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06910449NA · recruiting Hemithoracic Arc Radiotherapy Post Pleural Decortication · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04802876Phase 2 · active not recruiting Efficacy of Tislelizumab and Spartalizumab Across Multiple Cancer-types in Patients with PD1-high MRNA Expressing Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06886672recruiting Genetic Susceptibility in MAlignant Pleural Mesothelioma: Clinical Implication of GermliNE variaTionS · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03560973Phase 2 · completed A Double Blind, Placebo Controlled, Randomized Phase II Study Evaluating Gemcitabine With or Without Ramucirumab , for II Line Treatment MPM · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04996017Phase 3 · recruiting Atezolizumab Versus Placebo for the Adjuvant Treatment of Malignant Pleural Mesothelioma (Atezomeso) · condition mapped PROBABILISTIC · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04213794early Phase 1 · terminated Heated Intra-peritoneal Chemotherapy With Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric Patients · condition mapped CURATED_BROADER · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04537715Phase 1 · completed Effects of Itraconazole and Rifampin on the Blood Tazemetostat Levels · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02349412Phase 3 · completed Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04177953Phase 2 · completed Nivolumab With Chemotherapy in Pleural Mesothelioma After Surgery · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03212404Phase 1 · active not recruiting Phase 1 Study of CK-301 (Cosibelimab) as a Single Agent in Subjects With Advanced Cancers · condition mapped CURATED_BROADER · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06469138Phase 1 · completed A Study to Investigate 14C-bemcentinib in Healthy Male Subjects · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05324436completed A Study of Yervoy and Opdivo Combination Therapy in Participants With Unresectable Advanced/Recurrent Malignant Pleural Mesothelioma (MPM) · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02648763terminated Staging Procedures to Diagnose Malignant Pleural Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04028479completed The Registry of Oncology Outcomes Associated With Testing and Treatment · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03656549Phase 4 · completed Dose Individualization of Pemetrexed - IMPROVE-I · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02784171Phase 2/Phase 3 · completed Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06726564Phase 1 · recruiting A Study of MT027 in Patients with Pleural Malignant Tumors · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01291420Phase 1/Phase 2 · completed Dendritic Cell Vaccination for Patients with Solid Tumors · condition mapped ONTOLOGY_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04985357withdrawn Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05228015Phase 1 · terminated Oral TEAD Inhibitor Targeting the Hippo Pathway in Subjects with Advanced Solid Tumors · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06652529Phase 1 · not yet recruiting Phase 1 Dose Escalation and Expansion to Evaluate AROG4-01 in Patients With Advanced Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04287829Phase 2 · active not recruiting Pembrolizumab Plus Lenvatinib In Second Line and Third Line Malignant Pleural mesotheLioma Patients · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06034860Phase 1 · terminated Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02040142Phase 2 · completed HIPEC for Peritoneal Carcinomatosis · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Peritoneal Mesothelial Neoplasm | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04843007completed Alvopem® (Pemetrexed) Safety Assessment · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02748798early Phase 1 · terminated Developing Optimal Parameters for Hyperpolarized Noble Gas and Inert Fluorinated Gas MRI of Lung Disorders · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06637345recruiting Identification of Prognostic and Predictive Biomarkers of Toxicity in Patients With Malignant Pleural Mesothelioma and Treated With High Doses of Radiotherapy (MESORTIBO) · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05215574Phase 1 · active not recruiting Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors · condition mapped CURATED_EXACT · 521 trials mapped (127 active) | — | — | Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01265433Phase 2 · completed Galinpepimut-S (WT-1 Analog Peptide) Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy · condition mapped ALIAS · 521 trials mapped (127 active) | — | — | Pleural Malignant Mesothelioma | 1 | Observed | clinicaltrials | graph → |